At RedLeaf Biologics, we have harnessed a breakthrough discovery in red sorghum to develop a new class of plant-based bioactives—backed by science and rooted in sustainability.
ReDaxin™ is the first and only patented red sorghum leaf extract, a phenolic-rich botanical extract powered by a one-in-two million natural adaptation and cultivated at scale using sustainable row crop agriculture. Clinically studied and formulation-ready, ReDaxin™ is built to meet the demands of dietary supplement, functional food and beverage, and cosmetic applications.
Promotes Strength & Recovery, Decreases Muscle Soreness During Recovery
Water-soluble, clean-label, pleasant flavor and aroma, stable across a broad pH spectrum, temperature, and light conditions
Self-affirmed GRAS, Non-GMO Project Verified, Kosher, Halal, Vegan, Gluten-Free, Made in America
At RedLeaf, we have discovered a rare, non-GMO genetic breakthrough in red sorghum to produce high-potency bioactives through traditional agriculture. Our red sorghum delivers unique phenolic compounds that are not typically found in commercial botanicals – through a proprietary aqueous extraction process.
Our experienced R&D team blends plant genetics, phytochemistry, and applied science to create our patented red sorghum.
Natural products with all the features and benefits of ReDaxin simply do not exist. This is a truly novel biomass producing a class of polyphenols widely studied in academia but never before available at a commercial scale.
As this year's winners, Redleaf Biologics will be joining SANS to present their companies and network in the industry.
What started in 2009 as a single anomalous plant out of 2 million has been developed into a distinct varietal of the ancient crop, with promising anti-inflammatory and antioxidant properties.
